2-Fucosyllactose

CAS No. 41263-94-9

2-Fucosyllactose( 2'-FL )

Catalog No. M25032 CAS No. 41263-94-9

2'-Fucosyllactose (2'-FL) is an oligosaccharide that could be derived from human milk.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 87 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    2-Fucosyllactose
  • Note
    Research use only, not for human use.
  • Brief Description
    2'-Fucosyllactose (2'-FL) is an oligosaccharide that could be derived from human milk.
  • Description
    2'-Fucosyllactose (2'-FL) is an oligosaccharide that could be derived from human milk. 2'-Fucosyllactose regulates the expression of CD14, alleviates colitis and regulates the gut microbiome. 2'-Fucosyllactose stimulates T cells to increase IFN-γ production and decreases IL-6, IL-17, and TNF-α production of cytokines.
  • In Vitro
    2'-Fucosyllactose (2'-FL; 0-12 mg/mL; 48 h) suppress cell-associated CD14 expression and to attenuate LPS (100 μg/mL) stimulated IL-8 secretion in T84 cells.2'-Fucosyllactose (2 mg/mL; 48 h; T84 and HCT8 cells) ameliorates inflammation induced by bacterial invasion. 2'-Fucosyllactose inhibits ETEC invasion and attenuated the consequent IL-8 secretion.2'-Fucosyllactose (2 mg/mL; 48 h; T84 and HCT8 cells) induces macrophage migration inhibitory factor signal pathways that suppress inflammation. Western Blot Analysis Cell Line:T84 cells Concentration:0, 2, and 4 mg/mL Incubation Time:48 hours Result:Suppressed CD14 mRNA and reduced cell-associated CD14 protein expression.Western Blot Analysis Cell Line:T84 and HCT8 cells T84 and HCT8 cells Concentration:2 mg/mL Incubation Time:48 hours Result:Suppressed CD14 mRNA and reduced cell-associated CD14 protein expression.Inhibited CD14 and NF-κB induction.Induced iκB and SOCS2 expression and STAT3 phosphorylation.
  • In Vivo
    2'-Fucosyllactose (2'-FL; 100 mg (200 μL); i.g.; daily, for 4 d; C57BL/6 mice with AIEC infection) inhibits AIEC infection and inflammation in vivo. Animal Model:C57BL/6 mice (8 weeks) with AIEC (uropathogenic E. coli, and adherent-invasive E. coli) infection Dosage:100 mg (200 μL)Administration:Oral gavage; daily, for 4 days Result:Had colons lengths were closer to normal.Inhibited the colonisation of the colonic mucosa by O83-positive bacteria.Decreased CD14 expression, CD14 mRNA levels, IL-6, IL-17 and TNF-α levels in colonic.
  • Synonyms
    2'-FL
  • Pathway
    Apoptosis
  • Target
    TNF
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    41263-94-9
  • Formula Weight
    488.44
  • Molecular Formula
    C18H32O15
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 50 mg/mL (102.37 mM)
  • SMILES
    O=C[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O[C@H]2[C@H]([C@@H]([C@@H]([C@@H](O2)C)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. He Y, et, al. The human milk oligosaccharide 2'-fucosyllactose modulates CD14 expression in human enterocytes, thereby attenuating LPS-induced inflammation. Gut. 2016 Jan;65(1):33-46. 2. Eiwegger T, et, al. Human milk--derived oligosaccharides and plant-derived oligosaccharides stimulate cytokine production of cord blood T-cells in vitro. Pediatr Res. 2004 Oct;56(4):536-40.
molnova catalog
related products
  • Tulisokibart

    Tulisokibart (PRA023) is a humanized anti-TNFSF15 monoclonal antibody used to study colon cancer.

  • Utomilumab

    Utomilumab (PF 05082566) is a humanized IgG2 antibody that targets the T-cell co-stimulatory receptor 4-1BB/CD137 and acts as a 4-1BB/CD137 agonist.

  • UCB-5307

    UCB-5307 is a small molecule compound that inhibits TNFR1 signal transduction and downstream function in vitro.